Trademark Search in Canada

AYRESVIQ

View On IC.GC.CA

REGISTERED

on 17 Nov 2023

Last Applicant/ Owned by

GLAXOSMITHKLINE BIOLOGICALS SA

Rue de l'Institut 89B-1330Rixensart,

Serial Number

2142012 filed on 21^st Oct 2021

Registration Number

TMA1209763 registered on 17^th Nov 2023

Registration expiry Date

17^th Nov 2033

Correspondent Address

NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L.,S.R.L.

1, Place Ville MarieSuite 2500, Montreal

QUEBEC

H3B1R1

AYRESVIQ

Trademark usage description

pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficien Read More

Classification Information

Class [005]
Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; vaccines namely prophylactic and therapeutic vaccines for humans.

Classification kind code

Mark Details

Serial Number

2142012

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 17^th Nov 2023	Registration Pending
Submitted for opposition 42 on 30^th Aug 2023	Advertised
Submitted for opposition 26 on 1^st Aug 2023	Approved
Submitted for opposition 27 on 1^st Aug 2023	Approval Notice Sent
Submitted for opposition 22 on 24^th Jan 2023	Search Recorded
Submitted for opposition 20 on 24^th Jan 2023	Examiner's First Report
Submitted for opposition 287 on 11^th Jul 2022	Pre-Assessment Letter Sent
Submitted for opposition 30 on 21^st Oct 2021	Filed
Submitted for opposition 1 on 21^st Oct 2021	Created
Submitted for opposition 31 on 21^st Oct 2021	Formalized